This process of identification, where tumors are both identified and assessed a threat level, helps to save patients from unnecessary medical treatments and costs, making for a more efficient and effective approach to treating prostate cancer.
May 31, 2016
Wall Street Journal references Michigan Prostate Score in article on new prostate cancer tests
The U-M Department of Urology's Michigan Prostate Score, also known as MiPS, was mentioned as one of the tests able to reduce unnecessary biopsies and treatments.